Inventor · disambiguated record
Robert Murray Mckinnell
Also filed as: MCKINNELL ROBERT M · MCKINNELL ROBERT MURRAY
74 granted patents·4 pending applications·461 citations·filing 2001–2023
99Inventor score
Files withTHERAVANCE BIOPHARMA R&D IP LLC22THERAVANCE INC18CHOI SEOK-KI12ALLEGRETTI PAUL9FATHEREE PAUL R6
Top patents by PatentIndex Score
78 records- 0198US7879896B2Dual-acting imidazole antihypertensive agentsTHERAVANCE INC·Filed 2008·Granted Feb 1, 2011·53 cites·30 claims
- 0298US7777077B2Dual-acting antihypertensive agentsTHERAVANCE INC·Filed 2008·Granted Aug 17, 2010·34 cites·34 claims
- 0397US11420965B2Pyrimidine compound as JAK kinase inhibitorTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2021·Granted Aug 23, 2022·3 cites·18 claims
- 0497US8013005B2Dual-acting antihypertensive agentsTHERAVANCE INC·Filed 2008·Granted Sep 6, 2011·42 cites·22 claims
- 0597US7834041B2Dual-acting antihypertensive agentsTHERAVANCE INC·Filed 2008·Granted Nov 16, 2010·29 cites·24 claims
- 0696US10988470B2Pyrimidine compound as JAK kinase inhibitorTHERAVANCE BIOPHARMA R & D IP LLC·Filed 2020·Granted Apr 27, 2021·3 cites·19 claims
- 0796US10562894B2Pyrimidine compound as JAK kinase inhibitorTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2019·Granted Feb 18, 2020·7 cites·19 claims
- 0896US10308646B2Pyrimidine compound as JAK kinase inhibitorTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2018·Granted Jun 4, 2019·11 cites·32 claims
- 0996US8372984B2Dual-acting oxazole antihypertensive agentsTHERAVANCE INC·Filed 2010·Granted Feb 12, 2013·16 cites·15 claims
- 1094US7989484B2Dual-acting antihypertensive agentsTHERAVANCE INC·Filed 2009·Granted Aug 2, 2011·25 cites·21 claims
- 1194US7956054B2Dual-acting pyrazole antihypertensive agentsTHERAVANCE INC·Filed 2010·Granted Jun 7, 2011·21 cites·16 claims
- 1294US7863309B2Dual-acting antihypertensive agentsTHERAVANCE INC·Filed 2009·Granted Jan 4, 2011·27 cites·27 claims
- 1394US7759363B2Benzimidazole-carboxamide compounds as 5-HT4, receptor agonistsTHERAVANCE INC·Filed 2006·Granted Jul 20, 2010·18 cites·18 claims
- 1493US10696656B2Benzimidazole-carboxamide compounds as 5-HT4 receptor agonistsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2019·Granted Jun 30, 2020·2 cites·21 claims
- 1593US8212052B2Dual-acting benzoimidazole antihypertensive agentsCHOI SEOK-KI·Filed 2008·Granted Jul 3, 2012·23 cites·23 claims
- 1692US8377964B2Benzimidazole-carboxamide compounds as 5-HT4 receptor agonistsTHERAVANCE INC·Filed 2010·Granted Feb 19, 2013·10 cites·17 claims
- 1792US8158659B2Dual-acting imidazole antihypertensive agentsALLEGRETTI PAUL·Filed 2010·Granted Apr 17, 2012·11 cites·32 claims
- 1891US7662815B2Diaryl ether β2 adrenergic receptor agonistsTHERAVANCE INC·Filed 2007·Granted Feb 16, 2010·15 cites·16 claims
- 1990US10233172B2Benzimidazole-carboxamide compounds as 5-HT4 receptor agonistsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2018·Granted Mar 19, 2019·4 cites·12 claims
- 2089US9975877B2Benzimidazole-carboxamide compounds as 5-HT4 receptor agonistsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2016·Granted May 22, 2018·4 cites·11 claims
- 2189US8143279B2Benzimidazole-carboxamide compounds as 5-HT4 receptor agonistsMCKINNELL ROBERT MURRAY·Filed 2006·Granted Mar 27, 2012·9 cites·8 claims
- 2288US12172994B2Pyrimidine compound as JAK kinase inhibitorTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2023·Granted Dec 24, 2024·0 cites·19 claims
- 2388US11254655B2Benzimidazole-carboxamide compounds as 5-HT4 receptor agonistsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2020·Granted Feb 22, 2022·1 cites·20 claims
- 2488US9428489B2Benzimidazole-carboxamide compounds as 5-HT4 receptor agonistsMCKINNELL ROBERT MURRAY·Filed 2014·Granted Aug 30, 2016·6 cites·8 claims
- 2588US7317023B2Diaryl ether β2 adrenergic receptor agonistsTHERAVANCE INC·Filed 2005·Granted Jan 8, 2008·10 cites·18 claims
- 2687US10538513B2Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitorsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2019·Granted Jan 21, 2020·4 cites·16 claims
- 2786US8344013B2Dual-acting imidazole antihypertensive agentsTHERAVANCE INC·Filed 2012·Granted Jan 1, 2013·4 cites·7 claims
- 2886US8236846B2Dual-acting antihypertensive agentsALLEGRETTI PAUL·Filed 2011·Granted Aug 7, 2012·5 cites·24 claims
- 2985US10392368B2Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitorsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2018·Granted Aug 27, 2019·5 cites·46 claims
- 3084US8921372B2Inhibitors of hepatitis C virusMCKINNELL ROBERT MURRAY·Filed 2011·Granted Dec 30, 2014·8 cites·18 claims
- 3184US8569351B2Dual-acting benzyl triazole antihypertensive agents having angiotensin II type receptor antagonist activity and neprilysin-inhibition activityALLEGRETTI PAUL·Filed 2012·Granted Oct 29, 2013·3 cites·3 claims
- 3284US8481549B2Dual-acting thiophene, pyrrole, thiazole and furan antihypertensive agentsFATHEREE PAUL R·Filed 2011·Granted Jul 9, 2013·5 cites·9 claims
- 3383US10968205B2Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitorsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2019·Granted Apr 6, 2021·1 cites·26 claims
- 3483US8895755B2Intermediates for preparing dual-acting benzyl triazole antihypertensive agents having angiotensin II type I receptor antagonist activity and neprilysin-inhibition activityALLEGRETTI PAUL·Filed 2013·Granted Nov 25, 2014·3 cites·1 claims
- 3583US8349875B2Dual-acting antihypertensive agentsTHERAVANCE INC·Filed 2012·Granted Jan 8, 2013·3 cites·24 claims
- 3683US8080572B2Dual-acting antihypertensive agentsCHOI SEOK-KI·Filed 2010·Granted Dec 20, 2011·5 cites·22 claims
- 3782US11160810B2Fused imidazo-piperidine JAK inhibitor compoundTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2019·Granted Nov 2, 2021·2 cites·27 claims
- 3882US9012485B2Dual-acting imidazole antihypertensive agentsCHOI SEOK-KI·Filed 2014·Granted Apr 21, 2015·2 cites·6 claims
- 3982US8119634B2Dual-acting pyrazole antihypertensive agentsBLAIR BROOKE·Filed 2011·Granted Feb 21, 2012·6 cites·11 claims
- 4081US2022274957A1Benzimidazole-carboxamide compounds as 5-ht4 receptor agonistsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2022·Application pending·0 cites
- 4180US10851102B2Imidazole and triazole containing bicyclic compounds as JAK inhibitorsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2020·Granted Dec 1, 2020·1 cites·19 claims
- 4280US7622467B2Aryl aniline derivatives as β2 adrenergic receptor agonistsTHERAVANCE INC·Filed 2005·Granted Nov 24, 2009·3 cites·16 claims
- 4378US8143298B2Dual-acting antihypertensive agentsCHOI SEOK-KI·Filed 2010·Granted Mar 27, 2012·1 cites·6 claims
- 4477US9273008B2Dual-acting imidazole antihypertensive agentsCHOI SEOK-KI·Filed 2015·Granted Mar 1, 2016·1 cites·6 claims
- 4577US8664254B2Dual-acting imidazole antihypertensive agentsCHOI SEOK-KI·Filed 2012·Granted Mar 4, 2014·1 cites·6 claims
- 4677US8106082B2Dual-acting antihypertensive agentsCHOI SEOK-KI·Filed 2010·Granted Jan 31, 2012·3 cites·22 claims
- 4776US9150514B2Dual-acting antihypertensive agentsALLEGRETTI PAUL·Filed 2014·Granted Oct 6, 2015·1 cites·26 claims
- 4875US8227497B2Dual-acting antihypertensive agentsALLEGRETTI PAUL·Filed 2011·Granted Jul 24, 2012·2 cites·20 claims
- 4973US6867299B2Oxamide IMPDH inhibitorsHOFFMANN LA ROCHE·Filed 2001·Granted Mar 15, 2005·7 cites·17 claims
- 5070US9216970B2Dual-acting thiophene, pyrrole, thiazole and furan antihypertensive agentsFATHEREE PAUL R·Filed 2014·Granted Dec 22, 2015·0 cites·9 claims
Showing the top 50 of 78 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →